勃林格殷格翰品牌怎么样申请店铺

我要投票

勃林格殷格翰在兽药行业中的票数：672 更新时间：2026-02-05

勃林格殷格翰是哪个国家的品牌？「勃林格殷格翰」是上海勃林格殷格翰药业有限公司旗下著名品牌。该品牌发源于德国，在1885年期间创立，经过多年的不懈努力和高速发展，现已成为行业的标杆品牌。

外推网助力勃林格殷格翰品牌出海！将品牌入驻外推网，定制勃林格殷格翰品牌推广信息，可以显著提高勃林格殷格翰产品曝光，简直是跨境电商爆单神器！目前仅需1000元/年哦~

兽药十大品牌，始于1885年德国，集人用药品/动物保健/生物制药为一体，致力于人类生物制药化学和动物健康产品研发，专注于生猪/家禽/宠物/牛的疫苗和药品领域

勃林格殷格翰 (Boehringer-Ingelheim)是一家专注人类生物制药化学和动物健康产品的医药公司。包括了处方药和保健消费品。是世界上颇大的私有制药企业。勃林格殷格翰是一家高度研发驱动的公司，始终专注药品的研究、开发、生产及推广。

勃林格殷格翰的核心业务是人用药品，包括处方药、自主保健品和工业客户业务（生物制药、药品生产和药用化学品）。勃林格殷格翰出产的药品一直被认为是治疗呼吸、心血管、中枢神经系统疾病及代谢紊乱、传染病的标杆。主要的研究领域包括免疫、肿瘤方面的适应症，目前多个具有治疗价值潜力的活性成分已经研发出来了。

勃林格殷格翰于1994年正式进入中国市场，目前在华投资总额超过2亿欧元，公司管理总部位于上海，业务遍布全国，拥有员工约3500名。勃林格殷格翰中国近年来发展迅速，包括人用药品、动物保健、生物制药3大业务板块并驾齐驱，协调发展，推动公司持续增长。

The top ten brand of veterinary medicine, started in 1885 in Germany, integrates human medicine / animal health care / biopharmaceutical as a whole, devotes to the research and development of human biopharmaceutical chemistry and animal health products, and focuses on the vaccine and drug field of pigs / Poultry / pets / cattle. Boehringer Ingelheim is a pharmaceutical company focusing on human biopharmaceutical chemistry and animal health products. It includes prescription drugs and health care consumer goods. It is a quite large private pharmaceutical enterprise in the world. Boehringer Ingelheim is a highly R & D driven company, which has always focused on the research, development, production and promotion of drugs. The core business of Boehringer Ingelheim is human drugs, including prescription drugs, independent health care products and industrial customer business (biopharmaceutical, pharmaceutical production and pharmaceutical chemicals). The drugs produced by Boehringer Ingelheim have been regarded as the benchmark for the treatment of respiratory, cardiovascular, central nervous system diseases, metabolic disorders and infectious diseases. The main research fields include immune and tumor indications. At present, a number of active ingredients with therapeutic potential have been developed. Boehringer Ingelheim officially entered the Chinese market in 1994. At present, the total investment in China is more than 200 million euros. The company's management headquarters is located in Shanghai, with businesses all over the country and about 3500 employees. In recent years, Boehringer Ingelheim has developed rapidly in China, including three business sectors of human drugs, animal health care and biopharmaceuticals, which are in line with each other, coordinated development and promoted the company's sustained growth.

本文链接： https://brand.waitui.com/a19fcecbe.html 联系电话：请联系客服添加联系邮箱：请联系客服添加